Overview
Egg phospholipids are primarily a mixture of naturally occurring phospholipids which are isolated from the egg yolk. Egg phospholipids are available as an intravenous fat emulsion indicated as a source of calories for patients requiring parenteral nutrition.
Indication
For use as a source of calories for patients requiring parenteral nutrition.
Associated Conditions
- Malnutrition
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| LIPOFUNDIN MCT/LCT INFUSION 20% | SIN05658P | INJECTION | 12.00g/1000ml | 4/8/1991 | |
| KABIVEN EMULSION FOR INFUSION | SIN11657P | INJECTION | 2.3 g/1000 ml | 9/4/2001 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| LIPOSYN III 20% | hospira healthcare ulc | 02366819 | Emulsion - Intravenous | 12 MG / ML | N/A |
| LIPOSYN III 10% | hospira healthcare ulc | 02366800 | Emulsion - Intravenous | 12 MG / ML | N/A |
| LIPOSYN II INJ 10% | hospira healthcare ulc | 00818712 | Emulsion - Intravenous | 700 MG / 100 ML | 1/1/1992 |
| LIPOSYN II 20% | hospira healthcare ulc | 00720968 | Emulsion - Intravenous | 1.2 % | 12/31/1987 |
| 20% TRAVAMULSION LIQ IV | baxter corporation clintec nutrition division | 02016036 | Liquid - Intravenous | 1.2 G / 100 ML | 12/31/1995 |
| LIPOSYN II 10% | hospira healthcare ulc | 00720976 | Emulsion - Intravenous | 0.9 % | 12/31/1987 |
| 10% TRAVAMULSION LIQ IV | baxter corporation clintec nutrition division | 02016028 | Liquid - Intravenous | 1.2 G / 100 ML | 12/31/1995 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.